<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for THRX</title>
    <link />
    <description>Headlines for Theravance, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Elan Explores Sale Options - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/101712/elan-explores-sale-options.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 17 Jun 2013 21:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Theravance Will Split Into 2 Companies After Losing Elan Bid</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/17/theravance-will-split-into-2-companies-after-losin/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 17 Jun 2013 13:23:00 GMT</pubDate>
    </item>
    <item>
      <title>Bank of America Reiterates Buy Rating on Theravance Following Elan Royalty Deal Rejection</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/06/3681487/bank-of-america-reiterates-buy-rating-on-theravance-foll.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 17 Jun 2013 11:12:33 GMT</pubDate>
    </item>
    <item>
      <title>Royalty Pharma's Offer for Elan Lapses</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130617-000146&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Mon, 17 Jun 2013 09:04:59 GMT</pubDate>
    </item>
    <item>
      <title>Elan Says Holders Do Not Approve Theravance/Elan Royalty Participation Deal</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/06/3680444/elan-says-holders-do-not-approve-theravanceelan-royalty-participation-deal.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 17 Jun 2013 08:20:53 GMT</pubDate>
    </item>
    <item>
      <title>Elan Shareholder Vote Nixes Royalty Pharma Takeover -- For Now</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11951549/1/elan-shareholder-vote-nixes-royalty-pharma-takeover--for-now.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Mon, 17 Jun 2013 07:44:00 GMT</pubDate>
    </item>
    <item>
      <title>Commit To Purchase Theravance At $25, Earn 13.2%</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11950838/1/commit-to-purchase-theravance-at-25-earn-132.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 14 Jun 2013 12:25:00 GMT</pubDate>
    </item>
    <item>
      <title>Theravance Inc. (THRX): Today's Featured Drugs Laggard</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11950174/1/theravance-inc-thrx-todays-featured-drugs-laggard.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 13 Jun 2013 17:01:00 GMT</pubDate>
    </item>
    <item>
      <title>Theravance's Management Presents at Goldman Sachs Healthcare Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1500722-theravance-s-management-presents-at-goldman-sachs-healthcare-conference-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 13 Jun 2013 15:43:02 GMT</pubDate>
    </item>
    <item>
      <title>AstraZeneca Buys Pearl for $1.15 Billion</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130610-000068&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Mon, 10 Jun 2013 05:04:59 GMT</pubDate>
    </item>
    <item>
      <title>Royalty Pharma Raises Elan Offer to $8 Billion</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130607-000486&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Fri, 07 Jun 2013 10:54:59 GMT</pubDate>
    </item>
    <item>
      <title>3 Top Pharma Stock Picks for the Long Term</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/30/3-top-pharma-stock-picks-for-the-long-term/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 30 May 2013 20:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Elan Rejects Royalty Offer Again - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/100179/elan-rejects-royalty-offer-again.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 24 May 2013 21:00:01 GMT</pubDate>
    </item>
    <item>
      <title>What Can We Earn If We Invest in the Top Five Holdings of the Baupost Group?</title>
      <link>http://www.fool.com/news/xt/gurufocus/www.gurufocus.com/news/219874/what-can-we-earn-if-we-invest-in-the-top-five-holdings-of-the-baupost-group.aspx</link>
      <author>GuruFocus</author>
      <pubDate>Fri, 24 May 2013 20:06:40 GMT</pubDate>
    </item>
    <item>
      <title>Elan Rejects Latest Royalty Pharma Approach</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130523-000697&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Thu, 23 May 2013 14:55:00 GMT</pubDate>
    </item>
    <item>
      <title>Royalty Pharma Lowers Acceptance Threshold For Elan Offer</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130523-000434&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Thu, 23 May 2013 08:17:00 GMT</pubDate>
    </item>
    <item>
      <title>Elan Provides Strategic Update - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99836/elan-provides-strategic-update.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 21 May 2013 21:16:01 GMT</pubDate>
    </item>
    <item>
      <title>When Savvy Dealmaking Borders on Reckless Spending</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/21/when-savvy-dealmaking-borders-on-reckless-spending/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 21 May 2013 18:27:00 GMT</pubDate>
    </item>
    <item>
      <title>The 3 Deadliest Diseases in the U.S.</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/19/the-3-deadliest-diseases-in-the-us/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 19 May 2013 14:00:00 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/18/this-week-in-biotech-27/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 18 May 2013 13:45:00 GMT</pubDate>
    </item>
  </channel>
</rss>
